Injectable peptide rapidly reduces intracranial pressure
A study for idiopathic intercranial hypertension is the first to show rapid and a major reduction in brain pressure and monthly headaches.
Source: europeanpharmaceuticalreview.com
Professor Alex Sinclair News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Professor Alex Sinclair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Professor Alex Sinclair Today - Breaking & Trending Today
Invex Therapeutics approved to start Presendin phase three clinical trial in Australia
Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been given the green light to start its EVOLVE phase three clinical trial in Australia on patients with idiopathic intracranial hypertension (IIH).
Source: smallcaps.com.au
Invex Therapeutics gains UK regulatory approval for clinical trial of Presendin to treat idiopathic intracranial hypertension
Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has received regulatory approval to commence an EVOLVE Phase III clinical trial in the United Kingdom for patients with idiopathic intracranial hypertension (IIH).
Source: smallcaps.com.au
Mum's joy as son's artwork captures symptoms of her rare condition
Alister’s winning artwork "I was diagnosed when I was 18, almost 30 years ago. Since then I've had two brain surgeries and struggle with symptoms everyday." Those symptoms include nausea every morning and headaches around the clock, as well as a constantly weakness in her left side, both arm and leg. On top of that Fern also deals with extreme tiredness, whooshing sounds in her ears and ocular migraines where the floor seems to move. "There are also olfactory hallucinations, basically smelling things that's not there like smoke," she added. "It's not easy," she said, "but for Alister to sho...
Source: belfasttelegraph.co.uk